WOCKHARDT BIO AG Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WOCKHARDT BIO AG, and what generic and branded alternatives to WOCKHARDT BIO AG drugs are available?
WOCKHARDT BIO AG has thirty-five approved drugs.
Summary for WOCKHARDT BIO AG
US Patents: | 0 |
Tradenames: | 29 |
Ingredients: | 29 |
NDAs: | 35 |
Drug Master File Entries: | 10 |
PTAB Cases with WOCKHARDT BIO AG as petitioner: | See PTAB cases with WOCKHARDT BIO AG as petitioner |
Drugs and US Patents for WOCKHARDT BIO AG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wockhardt Bio Ag | NYSTATIN | nystatin | SUSPENSION;ORAL | 062512-001 | Oct 29, 1984 | AA | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wockhardt Bio Ag | CLEMASTINE FUMARATE | clemastine fumarate | SYRUP;ORAL | 074863-001 | Mar 13, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wockhardt Bio Ag | AMOXICILLIN | amoxicillin | FOR SUSPENSION;ORAL | 065319-002 | Jun 18, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.